找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines; Manmohan Singh Book 2013 Springer Science+Business Media

[复制链接]
查看: 10220|回复: 56
发表于 2025-3-21 16:04:09 | 显示全部楼层 |阅读模式
书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
编辑Manmohan Singh
视频video
概述Focus on the future of vaccines.Addresss delivery systems for vaccines.Explore the use of nanoparticles in vaccine delivery?
图书封面Titlebook: Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines;  Manmohan Singh Book 2013 Springer Science+Business Media
描述Development of new-generation vaccines is now more challenging than ever, as identifying, purifying and evaluating vaccine antigens is a complex undertaking. Most importantly, once the relevant antigens have been identified, key focus then shifts to the development of suitable delivery systems and formulations to achieve maximum in vivo potency with minimum potential side effects. These novel formulations—many of which will be nanoparticulates—can deliver the antigens to the desired site, to the relevant antigen presenting cells, and prevent systemic exposure of the immune potentiators. The proposed book will outline all the critical steps that need to be considered for successful development of various types of nanoparticulate delivery systems for vaccine antigens. These contributions from leading experts in the area of vaccine formulation and delivery systems will tie in what is the most current status, including clinical evaluations with these novel vaccine technologies.​
出版日期Book 2013
关键词Adjuvants; Immunity; Vaccines
版次1
doihttps://doi.org/10.1007/978-1-4614-5380-2
isbn_softcover978-1-4899-9228-4
isbn_ebook978-1-4614-5380-2
copyrightSpringer Science+Business Media New York 2013
The information of publication is updating

书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines影响因子(影响力)




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines影响因子(影响力)学科排名




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines网络公开度




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines网络公开度学科排名




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines被引频次




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines被引频次学科排名




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines年度引用




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines年度引用学科排名




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines读者反馈




书目名称Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:36:50 | 显示全部楼层
Preclinical and Clinical Development of Synthetic ,NKT-Cell Glycolipid Agonists as Vaccine Adjuvantsss a semi-invariant T-cell receptor (TCR), Vα14-Jα18 paired with Vβ8.2, Vβ7 or Vβ2 in mice and Vα24-Jα18/Vβ11 in human [1–5]. These cells are referred to as .NKT cells type I NKT cells, or NKT cells, in contrast to type II NKT cells comprising the remaining NKT cells expressing non-invariant TCR [6]
发表于 2025-3-22 03:59:54 | 显示全部楼层
Mucosal Vaccination: Opportunities and Challengeson. Mucosal surfaces, with a combined surface area of about 400 m. [1], are undoubtedly the major site of entry for most pathogens. Therefore, these vulnerable surfaces are associated with a large and highly specialized innate and adaptive mucosal immune system that protects the surfaces and the bod
发表于 2025-3-22 07:55:41 | 显示全部楼层
发表于 2025-3-22 12:24:18 | 显示全部楼层
发表于 2025-3-22 16:17:32 | 显示全部楼层
High Throughput Screening for Stabilizers of Vaccine Antigensed, its conversion into an efficacious, safe, convenient, and stable dosage form that can be effectively delivered to a target population is often beset with numerous difficulties. Not the least of these is the many different types of vaccine antigens, each with its own individual chemical identity,
发表于 2025-3-22 17:40:02 | 显示全部楼层
发表于 2025-3-23 00:14:59 | 显示全部楼层
Current Status of Electroporation Technologies for Vaccine Deliveryby the plasmid and controlled by mammalian promoters, the stage was set for the investigation of the range of compelling applications for endogenous expression of proteins in animals and humans [1]. The finding that simple injection of purified plasmid DNA into a target tissue could induce sustained
发表于 2025-3-23 02:46:17 | 显示全部楼层
Microneedles for Intradermal Vaccination: Immunopotentiation and Formulation Aspects. Ease of administration, improved immune protection, antigen dose sparing, and independence of cold-chain distribution are among the many potential benefits that the technology can introduce in the field [2]. Due to the same advantages, microneedle-based vaccines, and intradermal vaccination in gen
发表于 2025-3-23 08:00:55 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 06:19
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表